Clinical utility of pentraxin (PTX3) for inflammatory marker in patients with infections in digestive organs

Clinical utility of pentraxin (PTX3) for inflammatory marker in patients with infections in digestive organs - Clinical utility of PTX3 in digestive infections

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004817

Enrollment

120

Registered

2011-02-01

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infections in digestive organs

Interventions

Entry period:Feburary 1, 2011-September 30,2012 Patients: Biriary tract infection, hepatitis and subacute bacterial peritonitis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with biriary tract infection, hepatitis and subacute bacterial peritonitis

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
PTX3 titer	—

Countries

Japan

Contacts

Public ContactShingo kato

Saitama Medical Center, Saitama Medical University Department of Gastroenterology and Hepatology

skato@saitama-med.ac.jp049-228-3564

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026